Total Payments
$511,578
2024 Payments
$38,683
Companies
47
Transactions
1,393
Medicare Patients
3,945
Medicare Billing
$589,459
Payment Breakdown by Category
Other$436,027 (85.2%)
Food & Beverage$29,082 (5.7%)
Travel$24,546 (4.8%)
Consulting$21,206 (4.1%)
Education$557.68 (0.1%)
Research$99.19 (0.0%)
Gifts$59.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $410,332 | 319 | 80.2% |
| Food and Beverage | $29,082 | 847 | 5.7% |
| Travel and Lodging | $24,546 | 165 | 4.8% |
| Consulting Fee | $21,206 | 13 | 4.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $19,533 | 13 | 3.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $6,163 | 2 | 1.2% |
| Education | $557.68 | 31 | 0.1% |
| Unspecified | $99.19 | 2 | 0.0% |
| Gift | $59.40 | 1 | 0.0% |
Payments by Type
General
$511,478
1,391 transactions
Research
$99.19
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $170,414 | 307 | $0 (2024) |
| Lilly USA, LLC | $114,938 | 288 | $0 (2024) |
| Abbott Laboratories | $72,759 | 108 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $65,251 | 145 | $0 (2022) |
| Amgen Inc. | $34,570 | 127 | $0 (2024) |
| ABBVIE INC. | $17,041 | 64 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $13,341 | 67 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $9,630 | 45 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $5,152 | 56 | $0 (2020) |
| Novo Nordisk AS | $3,335 | 9 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38,683 | 113 | Abbott Laboratories ($22,142) |
| 2023 | $56,823 | 162 | Abbott Laboratories ($21,442) |
| 2022 | $59,357 | 142 | Novo Nordisk Inc ($23,944) |
| 2021 | $89,892 | 192 | Novo Nordisk Inc ($34,275) |
| 2020 | $49,494 | 90 | Lilly USA, LLC ($13,363) |
| 2019 | $48,964 | 211 | Novo Nordisk Inc ($21,944) |
| 2018 | $63,986 | 186 | Novo Nordisk Inc ($18,689) |
| 2017 | $104,378 | 297 | Novo Nordisk Inc ($29,091) |
All Payment Transactions
1,393 individual payment records from CMS Open Payments — Page 1 of 56
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Bone Health | ||||||
| 12/18/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Hematology | ||||||
| 12/11/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: Diabetes Care | ||||||
| 11/25/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $31.16 | General |
| Category: Insulin Pump | ||||||
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,687.50 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $127.01 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: Diabetes Care | ||||||
| 11/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Travel and Lodging | In-kind items and services | $1,943.76 | General |
| Category: Diabetes Care | ||||||
| 11/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $111.61 | General |
| Category: Diabetes Care | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Endocrinology | ||||||
| 10/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,750.00 | General |
| Category: Diabetes Care | ||||||
| 10/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: Diabetes Care | ||||||
| 10/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $102.28 | General |
| Category: Diabetes Care | ||||||
| 10/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: Diabetes Care | ||||||
| 10/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Travel and Lodging | In-kind items and services | $60.30 | General |
| Category: Diabetes Care | ||||||
| 10/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Travel and Lodging | In-kind items and services | $53.60 | General |
| Category: Diabetes Care | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Obesity | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| safety and efficacy linagliptin vs SU | Boehringer Ingelheim b.v. | $99.19 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 982 | 2,772 | $444,803 | $133,602 |
| 2022 | 12 | 1,023 | 2,942 | $482,388 | $146,873 |
| 2021 | 13 | 876 | 3,540 | $313,579 | $150,356 |
| 2020 | 14 | 1,064 | 4,526 | $360,448 | $158,628 |
Total Patients
3,945
Total Services
13,780
Medicare Billing
$589,459
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 525 | 943 | $325,335 | $88,936 | 27.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 14 | 1,080 | $36,720 | $19,334 | 52.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 38 | 47 | $16,215 | $4,380 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 54 | $13,230 | $3,837 | 29.0% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 38 | 41 | $14,125 | $3,433 | 24.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 180 | 315 | $4,095 | $2,646 | 64.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 49 | 91 | $8,372 | $2,539 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $8,493 | $2,475 | 29.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 34 | $6,290 | $2,254 | 35.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 21 | 21 | $5,145 | $1,331 | 25.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 30 | $3,000 | $1,240 | 41.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 97 | $3,783 | $1,197 | 31.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 543 | 973 | $335,685 | $94,295 | 28.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 14 | 1,260 | $42,840 | $21,697 | 50.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 42 | 59 | $28,615 | $8,972 | 31.4% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 53 | 62 | $20,250 | $5,485 | 27.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 78 | $19,110 | $5,280 | 27.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 25 | 28 | $9,660 | $3,179 | 32.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 41 | $7,585 | $2,511 | 33.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $7,599 | $2,250 | 29.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 199 | 334 | $4,342 | $989.22 | 22.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 28 | $2,800 | $925.52 | 33.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 20 | 28 | $2,576 | $848.20 | 32.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 18 | 34 | $1,326 | $442.06 | 33.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 528 | 898 | $175,110 | $88,096 | 50.3% |
About Dr. John Gilbert, M.D
Dr. John Gilbert, M.D is a Internal Medicine healthcare provider based in Fullerton, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1588650667.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Gilbert, M.D has received a total of $511,578 in payments from pharmaceutical and medical device companies, with $38,683 received in 2024. These payments were reported across 1,393 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($410,332).
As a Medicare-enrolled provider, Gilbert has provided services to 3,945 Medicare beneficiaries, totaling 13,780 services with total Medicare billing of $589,459. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Fullerton, CA
- Active Since 09/23/2005
- Last Updated 10/19/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1588650667
Products in Payments
- FARXIGA (Drug) $60,759
- Ozempic (Drug) $48,728
- FREESTYLE LIBRE 3 (Device) $43,583
- Rybelsus (Drug) $39,849
- LYUMJEV (Drug) $39,052
- Repatha (Biological) $33,607
- HUMULIN (Drug) $27,477
- Tresiba (Drug) $25,379
- RYBELSUS (Drug) $21,515
- FreeStyle Libre Pro (Device) $15,013
- JARDIANCE (Drug) $13,452
- Synthroid (Drug) $9,935
- SOLIQUA 100/33 (Biological) $8,589
- Victoza (Drug) $8,208
- FREESTYLE LIBRE (Device) $7,706
- FREESTYLE LIBRE 2 (Device) $6,205
- INVOKANA (Drug) $5,080
- Androgel (Drug) $4,979
- Xultophy 100/3.6 (Drug) $4,705
- BYDUREON (Drug) $4,232
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fullerton
Monica Lee, M.d, M.D
Internal Medicine — Payments: $31,821
Internal Medicine $31,821
Maximiliano Hyon, D.o, D.O
Internal Medicine — Payments: $25,037
Internal Medicine $25,037
Jay Kim, M.d, M.D
Internal Medicine — Payments: $23,798
Internal Medicine $23,798
Scott Sainburg, M.d, M.D
Internal Medicine — Payments: $14,644
Internal Medicine $14,644
Steven Saltman, M.d, M.D
Internal Medicine — Payments: $9,276
Internal Medicine $9,276
Ramesh Rathod, M.d, M.D
Internal Medicine — Payments: $8,189
Internal Medicine $8,189